Vida Health announced new research demonstrating significantly lowered A1C levels with its virtual cardiometabolic program.
The research highlighted use of the program in low-income Medicare Advantage members. Significantly lowered A1C levels even occurred in areas with limited income and food access.
Vida Health’s study compared its members living in areas of low income and low access to food with members living elsewhere. The study classified such low-income areas using the USDA’s Food Access Research Atlas.
Results demonstrated that, irrespective of socioeconomic barriers, Vida interventions led to an average A1C reduction of -1.38 points. This occurred in individuals with a baseline A1C level greater than or equal to 9. The company said this underscores its program’s effectiveness in delivering equitable care.
“Diabetes is a complex disease that is heavily influenced by social determinants of health,” said Dr. Richard Frank, chief medical officer for Vida Health. “Nearly half of Americans struggle to pay for basic necessities like housing and food. At Vida, we understand that healthy living can be challenging, with many aspects out of the individual’s control. We’re committed to providing the highest quality services and resources to help promote nutritional health for anyone, regardless of where they are on their personal health journey, or what type of access they have.”
Vida’s intervention included remote sessions with Registered Dietitians and Certified Diabetes Care and Education Specialists. It also offered content related to goal-setting to account for social determinants of health (SDOH).
The company said its findings suggest the ability to deliver equitable care across SDOH barriers. Vida also said interventions that target SDOH as part of diabetes management can offer effectiveness in improving glycemic control in this population.